[{"Assets_0_Q3_USD":110672000.0,"CommonStockSharesOutstanding_0_Q3_shares":114082000.0,"EarningsPerShareBasic_1_Q3_USD":0.12,"EarningsPerShareBasic_3_Q3_USD":0.27,"EarningsPerShareDiluted_1_Q3_USD":0.11,"EarningsPerShareDiluted_3_Q3_USD":0.25,"NetIncomeLoss_1_Q3_USD":13757000.0,"NetIncomeLoss_3_Q3_USD":30792000.0,"StockholdersEquity_0_Q3_USD":86302000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":125651000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":123417000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":113603000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":113242000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171103"}]